Please login to the form below

Not currently logged in
Email:
Password:

empathy

This page shows the latest empathy news and features for those working in and with pharma, biotech and healthcare.

Novartis, Molecular Partners launch global study of novel COVID-19 drug

Novartis, Molecular Partners launch global study of novel COVID-19 drug

The newly launched phase 2/3 EMPATHY trial will explore the use of ensovibep for the treatment of COVID-19 patients who are in the early stages of infection. ... Novartis will also seek a US Food and Drug Administration (FDA) emergency use authorisation

Latest news

More from news
Approximately 0 fully matching, plus 37 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 44 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....